ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 156 filers reported holding ACORDA THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,415,000 | +49.9% | 2,051,657 | +11.8% | 0.01% | +25.0% |
| Q3 2020 | $944,000 | -30.9% | 1,835,064 | -1.4% | 0.00% | -33.3% |
| Q2 2020 | $1,367,000 | -22.5% | 1,861,996 | -1.7% | 0.01% | -40.0% |
| Q1 2020 | $1,765,000 | -53.6% | 1,893,678 | +1.6% | 0.01% | -41.2% |
| Q4 2019 | $3,801,000 | -9.6% | 1,864,454 | +27.4% | 0.02% | -5.6% |
| Q3 2019 | $4,205,000 | -51.7% | 1,464,021 | +29.1% | 0.02% | -57.1% |
| Q2 2019 | $8,700,000 | -29.1% | 1,134,303 | +22.9% | 0.04% | -20.8% |
| Q1 2019 | $12,268,000 | +34.6% | 923,041 | +57.9% | 0.05% | +17.8% |
| Q4 2018 | $9,113,000 | +1.7% | 584,747 | +28.2% | 0.04% | +21.6% |
| Q3 2018 | $8,961,000 | +311.4% | 455,987 | +500.7% | 0.04% | +311.1% |
| Q2 2018 | $2,178,000 | +47.0% | 75,915 | +21.3% | 0.01% | +50.0% |
| Q1 2018 | $1,482,000 | +176.0% | 62,603 | +150.1% | 0.01% | +200.0% |
| Q4 2017 | $537,000 | -52.6% | 25,027 | -43.6% | 0.00% | -66.7% |
| Q2 2016 | $1,133,000 | +55.6% | 44,361 | +105.4% | 0.01% | +50.0% |
| Q2 2014 | $728,000 | +313.6% | 21,597 | +257.5% | 0.00% | +300.0% |
| Q4 2013 | $176,000 | +39.7% | 6,041 | +64.5% | 0.00% | 0.0% |
| Q3 2013 | $126,000 | – | 3,672 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|